Cystic Fibrosis Carrier Screening Practices in an Ethnically Diverse Region: Experience of the Genetic Network of the Empire State, Puerto Rico, and the U.S. Virgin Islands

1999 ◽  
Vol 3 (2) ◽  
pp. 215-218 ◽  
Author(s):  
ELINOR LANGFELDER SCHWIND ◽  
MARILYN WOLFE ◽  
KAREN GREENDALE ◽  
LAVANYA M. MISRA ◽  
KENNETH A. PASS ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Puerto Rico ◽  
Ethnically Diverse ◽  
Genetic Network ◽  
Virgin Islands ◽  
Carrier Screening ◽  
Screening Practices ◽  
Cystic Fibrosis Carrier ◽  
Cystic Fibrosis Carrier Screening ◽  
The U.S

VP103 Health Technology Assessment Of Genetic Tests For Cystic Fibrosis Carrier Screening In Italy

2017 ◽  
Vol 33 (S1) ◽  
pp. 197-197
Author(s):  
Vladimir Vukovic ◽  
Antonella Agodi ◽  
Baroukh Assael ◽  
Giovanna Elisa Calabro' ◽  
Paolo Campanella ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Health Technology Assessment ◽  
Technology Assessment ◽  
Genetic Disorder ◽  
Health Technology ◽  
Carrier Screening ◽  
Cost Of Care ◽  
Genetic Tests ◽  
Cystic Fibrosis Carrier ◽  
Cystic Fibrosis Carrier Screening

INTRODUCTION:Cystic Fibrosis (CF) is a genetic disorder caused by mutations in CFTR gene. In Italy, reported prevalence is approximately .70 per 10,000 inhabitants (1). The practice and recommendations for Cystic Fibrosis carrier screening are very heterogeneous in Europe. A proposal of a carrier genetic test in the general population raises many questions. Health Technology Assessment (HTA) could offer a sound methodological basis for this evaluation. The aim of this work was to summarize the available evidence, using the HTA approach, on the genetic tests for Cystic Fibrosis carrier screening.METHODS:A systematic literature search was used to find the best available international and national evidence on genetics test for CF carrier screening. In this report, we specifically addressed the health problem of disease, description and technical characteristics of tests – its analytic and clinical validity, and clinical utility. Economic evaluation of different scenarios was synthesized from the literature. Ethical, organizational, and social aspects of CF and genetic screening were also considered.RESULTS:Several screening strategies have been evaluated in the literature and screening options can be characterized by different timing, model and place of screening (2). The reported cost of a screening test ranged from EUR25 to EUR212 (3). Estimated life time cost of care for CF patients ranged from EUR291,048 to EUR1,105,452. Ethical analysis emphasized that the use of these tests is an advantage in terms of the acquisition of knowledge and of responsible management of choices, but at the same time raises many ethical questions. Social considerations reported among patients and their families an overall positive attitude toward population CF carrier screening.CONCLUSIONS:The advances in the molecular genetics technology have made CF carrier testing reliable and affordable. The multidisciplinary approach of this HTA provided an evidence-based evaluation of genetic tests and offers a firm scientific background for the decision-makers to consider the implementation of a screening for Cystic Fibrosis carriers into the Italian health care system.

Preconception Cystic Fibrosis Carrier Screening: Costs and Consequences

2005 ◽  
Vol 9 (2) ◽  
pp. 158-166 ◽  
Author(s):  
Francis A.M. Weijers-Poppelaars ◽  
Mark F. Wildhagen ◽  
Lidewij Henneman ◽  
Martina C. Cornel ◽  
Leo P. Ten Kate
Keyword(s):  
Cystic Fibrosis ◽  
Carrier Screening ◽  
Cystic Fibrosis Carrier ◽  
Cystic Fibrosis Carrier Screening

scholarly journals Cystic fibrosis carrier screening in a North American population

2013 ◽  
Vol 16 (7) ◽  
pp. 539-546 ◽  
Author(s):  
Val V. Zvereff ◽  
Hawazin Faruki ◽  
Marcia Edwards ◽  
Kenneth J. Friedman
Keyword(s):  
Cystic Fibrosis ◽  
North American ◽  
Carrier Screening ◽  
North American Population ◽  
American Population ◽  
Cystic Fibrosis Carrier ◽  
Cystic Fibrosis Carrier Screening

scholarly journals Deciding on cystic fibrosis carrier screening: three citizens’ juries and an online survey

2018 ◽  
Vol 28 (5) ◽  
pp. 973-977 ◽  
Author(s):  
Paola Mosconi ◽  
Cinzia Colombo ◽  
Anna Roberto ◽  
Giulia Candiani ◽  
Maria Teresa Greco ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Online Survey ◽  
Carrier Screening ◽  
Cystic Fibrosis Carrier ◽  
Cystic Fibrosis Carrier Screening
Sign in / Sign up

Export Citation Format

Share Document